Allogeneic Cellular Vaccine 1650-G
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Allogeneic Cellular Vaccine 1650-G, covering 2013-05-20 to 2013-05-20. Get the full timeline:
Most recent: Clinical Trial Update: Allogeneic Cellular Vaccine 1650-G for Non-Small Cell Lung Cancer [Phase 2]